Jump Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.26M Buy
+338,315
New +$5.18M 0.06% 367
2026
Q1
Sell
-204,500
Closed -$3.32M 1833
2025
Q4
$3.32M Buy
204,500
+161,600
+377% +$2.64M 0.04% 493
2025
Q3
$642K Sell
42,900
-140,943
-77% -$1.72M 0.01% 1195
2025
Q2
$2.14M Buy
+183,843
New +$1.67M 0.02% 702
2024
Q4
Sell
-120,020
Closed -$615K 1590
2024
Q3
$615K Buy
120,020
+33,185
+38% +$145K 0.01% 1022
2024
Q2
$314K Sell
86,835
-97,944
-53% -$311K 0.01% 1363
2024
Q1
$593K Buy
184,779
+149,113
+418% +$577K 0.02% 1077
2023
Q4
$175K Buy
35,666
+12,072
+51% +$55.1K 0.01% 1595
2023
Q3
$129K Sell
23,594
-19,695
-45% -$130K ﹤0.01% 1638
2023
Q2
$290K Buy
43,289
+19,023
+78% +$141K 0.01% 1323
2023
Q1
$214K Sell
24,266
-74,410
-75% -$656K 0.01% 1283
2022
Q4
$754K Buy
98,676
+50,576
+105% +$393K 0.04% 605
2022
Q3
$342K Sell
48,100
-64,489
-57% -$607K 0.01% 1076
2022
Q2
$911K Sell
112,589
-8,731
-7% -$76.8K 0.04% 614
2022
Q1
$1.68M Buy
+121,320
New +$1.91M 0.07% 334
2021
Q2
Sell
-14,567
Closed -$586K 1048
2021
Q1
$586K Buy
+14,567
New +$788K 0.05% 360

Other funds holding ADPT

Jump Financial's ADPT Position: Q2 2026 in Review

Jump Financial opened a new position in Adaptive Biotechnologies (ADPT) in Q2 2026: 338,315 shares worth $7.26M. The stake represents 0.06% of the portfolio and ranks #367 among its holdings. This is a return to the name: Jump Financial previously reported a position in ADPT as recently as Q4 2025.

Jump Financial first reported a position in ADPT in Q1 2021 and has held it in 16 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Jump Financial held 338,315 shares of Adaptive Biotechnologies worth $7.26M as of Q2 2026.
  • Adaptive Biotechnologies was a new Jump Financial position in Q2 2026.
  • Adaptive Biotechnologies made up 0.06% of Jump Financial's portfolio in Q2 2026, its #367 holding.
  • Jump Financial first reported a position in Adaptive Biotechnologies in Q1 2021 and has held it in 16 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.